CERAD Neuropsychologische Testbatterie

Aebi, C. Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi-Center Studie. 2002, Doktorarbeit, Universität Basel. (1.17 MB)

Berres M, Monsch AU, Bernasconi F, Thalmann B, Stähelin HB. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Studies in Health Technology and Informatics 2000; 77: 195-199. (864 KB)

Ehrensperger MM, Berres M, Taylor KI, Monsch AU. Early detection of Alzheimer's disease with a total score of the German CERAD. Journal of the International Neuropsychological Society 2010; 16: 910-920. (190 KB)

Mistridis P, Egli SC, Iverson GL, Berres M, Willmes K, Welsh-Bohmer KA, Monsch AU. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer’s Disease - Neuropsychological Assessment Battery (CERAD-NAB). Eur Arch Psychiatry Clin Neurosci 2015;165:407-17. (921 KB)

Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI. The 12 years preceding Mild Cognitive Impaiment due to Alzheimer's disease: The temporal emergence of cognitive decline. J Alzheimers Dis 2015;48:1095-107. (461 KB)

Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 1988;24(4):641-52.

Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989 Sep;39(9):1159-65.

Pflüger M, Aebi C, Monsch AU. Klinische Untersuchungsverfahren. Zeitschrift für Klinische Psychologie und Psychotherapie 2003; 32(1): 64-67. (35 KB)

Schmid NS, Ehrensperger MM, Berres M, Beck IR, Monsch AU. The extension of the German CERAD-Neuropsychological Assessment Battery with tests assessing subcortical, executive and frontal functions improves accuracy in dementia diagnosis. Geriatr Cogn Disord Extra 2014;4:322-34. (1.47 MB)

Thalmann B, Monsch AU, Bernasconi F, Schneitter M, Aebi C, Camachova-Davet Z, Stähelin HB. The CERAD Neuropsychological Assessment Battery (CERAD-NAB) - A Minimal Data Set as a Common Tool for German-speaking Europe. Poster presented at the International Conference on Alzheimer Disease and Related Disorders, Washington DC, USA 2000. (175.81 KB)

Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 1991 Mar;48(3):278-81.

Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994, 44, 609– 614.

Zehnder AE, Bläsi S, Berres M, Spiegel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer Disease? American Journal of Alzheimer’s Disease and Other Dementias 2007; 22;(5):416-26. (408 KB)

Plus-Tests

Trail Making Test:

Army Individual Test Battery. Manual of directions and scoring. Washington, DC: War Department, Adjutant General’s Office., 1944.

Reitan R. Trail-making test. Arizona: Reitan Neuropsychology Laboratory, 1979.

Spreen O, Strauss E. A Compendium of neuropsychological tests: Administration, norms, and commentary. NY: Oxford University Press, 1991.

S-Wörter / Phonematische Flüssigkeit:

Spreen FO, Benton AL. Manual of instructions for the Neurosensory Center Comprehensive Examination for Aphasia. Victoria, British Columbia, Canada: University of Victoria, 1977.

Thurstone LL. Primary mental abilities. Chicago: University of Chicago Press, 1938.